Topiramate
NDC product · U.S. Food and Drug Administration (openFDA) · United States
-
Product NDC
68462-218 -
Package NDC
68462-218-60 -
Application number
ANDA217869 -
SPL ID
e4d3b13a-e354-421d-917a-613ad0a3ab35 -
SPL set ID
872927eb-0b61-44bb-9892-3c700b6f2181 -
UNII
0H73WJJ391 -
RxCUI
205315 -
RxCUI
205316
What the source publishes
- Labeler
- Glenmark Pharmaceuticals Inc., USA
- Active ingredients
- Topiramate
- Form
- CAPSULE, COATED PELLETS
- Routes
- ORAL
- Administrative status
- present-in-source-snapshot
- Marketing status
- ANDA
- Product type
- HUMAN PRESCRIPTION DRUG
- Prescription
- Prescription or restricted
Names this record is found by
Complete source data
{
"name": "Topiramate",
"splId": "e4d3b13a-e354-421d-917a-613ad0a3ab35",
"labels": [
{
"setId": "872927eb-0b61-44bb-9892-3c700b6f2181",
"labelUrl": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=872927eb-0b61-44bb-9892-3c700b6f2181",
"labelPdfUrl": "https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=872927eb-0b61-44bb-9892-3c700b6f2181"
}
],
"routes": [
"ORAL"
],
"labeler": "Glenmark Pharmaceuticals Inc., USA",
"finished": true,
"packaging": [
{
"sample": false,
"description": "60 CAPSULE, COATED PELLETS in 1 BOTTLE (68462-218-60)",
"package_ndc": "68462-218-60",
"identifierStatus": "well-formed",
"marketing_start_date": "20240716"
}
],
"productId": "68462-218_e4d3b13a-e354-421d-917a-613ad0a3ab35",
"useDomain": "unknown",
"dosageForm": "CAPSULE, COATED PELLETS",
"productNdc": "68462-218",
"deaSchedule": null,
"genericName": "Topiramate",
"productType": "HUMAN PRESCRIPTION DRUG",
"listingStatus": "present-in-source-snapshot",
"targetSpecies": [],
"approvalStatus": "not-established-by-ndc-listing",
"labelAssociation": "openFDA-harmonized-set-ids; not a product-level approval match",
"marketingEndDate": null,
"activeIngredients": [
{
"name": "TOPIRAMATE",
"strength": "15 mg/1"
}
],
"applicationNumber": "ANDA217869",
"marketingCategory": "ANDA",
"stateRestrictions": {
"status": "not-collected",
"observations": []
},
"useDomainEvidence": {
"basis": "unreviewed",
"field": null,
"value": null,
"version": 1,
"sourceId": "us.fda.ndc"
},
"marketingStartDate": "20240716",
"targetSpeciesStatus": "not-reported",
"prescriptionCategory": "prescription-or-restricted",
"harmonizedIdentifiers": {
"nui": [
"N0000008486",
"N0000185506",
"N0000182140"
],
"upc": [
"0368462218600",
"0368462219607"
],
"unii": [
"0H73WJJ391"
],
"rxcui": [
"205315",
"205316"
],
"spl_set_id": [
"872927eb-0b61-44bb-9892-3c700b6f2181"
],
"pharm_class_pe": [
"Decreased Central Nervous System Disorganized Electrical Activity [PE]"
],
"pharm_class_moa": [
"Cytochrome P450 3A4 Inducers [MoA]",
"Cytochrome P450 2C19 Inhibitors [MoA]"
],
"manufacturer_name": [
"Glenmark Pharmaceuticals Inc., USA"
],
"is_original_packager": [
true
]
},
"listingExpirationDate": "20271231"
}
Read this record from your own software
The same record, with every field and its provenance, is one request away. An API key is free and works immediately.
curl -G "https://api.medifontis.com/v1/drugs/record" \
-H "Authorization: Bearer $MEDIFONTIS_API_KEY" \
--data-urlencode "country=us" \
--data-urlencode "sourceId=us.fda.ndc" \
--data-urlencode "id=us:fda:ndc:68462-218_e4d3b13a-e354-421d-917a-613ad0a3ab35"